Triple Giving November is underway! Until December 1, every gift is tripled—up to $500,000.
💰 $50 becomes $150
💰 $100 becomes $300
💰 $500 becomes $1,500
Your support moves #MECFS and #LongCOVID research forward.
👉 Donate hope today: ow.ly/2YSF5104KqS
Bloomberg Businessweek: “Chronic Fatigue Was Neglected for Decades. Then Came Covid.”
ME/CFS patients battled for recognition as researchers struggled for funding. The pandemic finally gave science the scale to start finding answers.
🔗 archive.ph/sVXML
“I am still becoming someone. Just not the person I once thought I would be.”
This month, we’re sharing a letter from a young woman living with ME/CFS — about friendships that faded, plans she had to let go, and what it means to still keep going.
👉 ow.ly/mMI551048Nk
“I am still becoming someone. Just not the person I once thought I would be.”
This month, we’re sharing a letter from a young woman living with ME/CFS — about friendships that faded, plans she had to let go, and what it means to still keep going.
👉 ow.ly/Xv7A51047xj
An exclusive conversation between OMF CEO Linda Tannenbaum and Dr. Daniel Peterson — a pioneer who refused to give up.
👉 Learn more and watch the interview: ow.ly/Qnz25103pBO
Dr. Peterson never gave up. Now it’s our turn to fund the discovery. From November 1 to December 1, every gift to OMF is tripled, up to $500,000.
🔗 Donate now: ow.ly/m7j85103pBN
🌟 Kick off a TRIPLE MATCH Fundraiser for OMF! 🌟
Follow this link to launch in as little as 60 seconds: omf.ngo/digital-fundraising-…. ALL donations to your fundraiser will be tripled between November 1 -December 1, 2026!
#MECFS #LongCOVID #pwME #pwLC
🌟 Triple Giving November is here 🌟
Through December 1, every gift to OMF is matched two-to-one, up to $500,000. Your $100 becomes $300. Triple your gift: ow.ly/iR0z5102Ixn
Tomorrow, Triple Giving November begins.
For one month, generous matching donors will triple every gift to OMF — up to $500,000. It’s the most powerful way to support #MECFS and #LongCOVID research all year.
🔗 Learn more: ow.ly/QQU05102HPk
You’re helping shape how we think about designing trials in our clinical trials network lite (CTN Lite) initiative. Join Dr. Danielle Meadows for a webinar on trial design considerations that apply across all CTN Lite trials.
🔗 REGISTER NOW: ow.ly/UPvh5101qaJ
Join the Long COVID International Conference 2026 and be part of the conversation!
Attend in person in Nice, France, or join virtually from anywhere in the world.
👉 Register today: amededu.co/3U3aDr1
#LongCOVIDIntl
@AcademicMedicalEducation
RECOVER-TLC’s third annual hybrid workshop is Nov. 4–5, 2026 — in person at The Bethesdan in Bethesda, MD, or virtually via Zoom.
🔗 Register (free): ow.ly/klSM50ZZxs9
Dr. Danielle Meadows shares OMF’s CTN Lite survey results on post-exertional symptom worsening in ME/CFS and how patient feedback is shaping decentralized, precision-medicine, patient-centered clinical trials.
👉 Watch the webinar recordings: youtube.com/watch?v=iq1Fcfey…
OMF Founder & CEO Linda Tannenbaum visited OMF’s ME/CFS Collaborative Research Center at Montreal earlier this month. Each member presented their work. “They are excited about their own research,” Linda said. That energy fuels everything we do. 💙
A treatment's mechanism of action is the specific biological process by which it produces its effect in the body.
Understanding mechanism of action helps clinicians make smarter, more personalized treatment choices for people living with ME/CFS & Long COVID.
OMF's Collaborative Center at Montreal is trialing treatments that target specific biological differences found in #MECFS based on what we already know of a drug’s mechanism of action.
🔗 Read more about this project: ow.ly/HOZM50ZXoUs
Why do people with Long COVID and ME/CFS wake up unrefreshed, even when a standard sleep study looks close to normal? A 2026 study in the journal SLEEP points to the fine-grained structure of sleep itself.
In this Journal Club, Dr. Danielle Meadows walks through "Facility-Measured Sleep Electroencephalographic Microstructures in Long COVID" (Sun et al., 2026), a paper from Dr. Janet Mullington's team in collaboration with OMF's Computational Research Center for Complex Diseases.
👉 Learn more about this publication: ow.ly/1Lvk50ZWh6r
👉 Watch Journal Club recording: ow.ly/Ys9B50ZWh6q













